Bacterial 5-2 adrenergic receptor

Berberine is currently being used to treat gastrointestinal-related medical disorders due to infections including bacterial diarrhea caused by Vibrio cholerae and Escherichia coli and intestinal parasites. The mechanism of the antidiarrheal activity of berberine has not been described yet. According to the study performed by Baker et al., berberine significantly inhibits myoelectric activity and transit of the small intestine that appears to be partially mediated by opioid and a-adrenergic receptors, concluding that the antidiarrheal properties of berberine may be mediated, at least in part, by its ability to delay small intestinal transit [67]. 

---